Zacks Research Comments on Perrigo FY2025 Earnings

Perrigo Company plc (NYSE:PRGO - Free Report) - Zacks Research issued their FY2025 earnings per share (EPS) estimates for Perrigo in a research note issued on Wednesday, May 28th. Zacks Research analyst S. Ganoria forecasts that the company will post earnings of $2.98 per share for the year. The consensus estimate for Perrigo's current full-year earnings is $2.56 per share. Zacks Research also issued estimates for Perrigo's Q1 2026 earnings at $0.61 EPS, Q4 2026 earnings at $1.02 EPS and FY2026 earnings at $3.26 EPS.

Separately, Wall Street Zen raised Perrigo from a "hold" rating to a "buy" rating in a report on Saturday, May 24th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus target price of $33.00.

Perrigo Stock Down 0.2%

Shares of Perrigo stock traded down $0.06 on Monday, reaching $26.71. 915,985 shares of the company were exchanged, compared to its average volume of 1,506,101. Perrigo has a 1-year low of $23.14 and a 1-year high of $30.93. The company has a market cap of $3.67 billion, a P/E ratio of -22.83 and a beta of 0.45. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The stock's 50 day moving average price is $26.10 and its 200-day moving average price is $26.19.

Perrigo (NYSE:PRGO - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.60 EPS for the quarter, topping analysts' consensus estimates of $0.56 by $0.04. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same period in the previous year, the company posted $0.29 earnings per share. The business's revenue for the quarter was down 3.5% on a year-over-year basis.

Perrigo Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 17th. Investors of record on Friday, May 30th will be issued a $0.29 dividend. This represents a $1.16 dividend on an annualized basis and a yield of 4.34%. The ex-dividend date of this dividend is Friday, May 30th. Perrigo's dividend payout ratio (DPR) is -88.55%.

Insider Activity at Perrigo

In other Perrigo news, EVP Ronald Craig Janish sold 7,800 shares of the business's stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the sale, the executive vice president now owns 33,666 shares in the company, valued at approximately $923,795.04. The trade was a 18.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Perrigo

Large investors have recently modified their holdings of the stock. Barclays PLC raised its stake in shares of Perrigo by 44.8% during the third quarter. Barclays PLC now owns 120,502 shares of the company's stock worth $3,160,000 after purchasing an additional 37,268 shares during the last quarter. Access Investment Management LLC purchased a new stake in shares of Perrigo during the fourth quarter worth approximately $7,989,000. Charles Schwab Investment Management Inc. raised its stake in shares of Perrigo by 1.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,048,005 shares of the company's stock worth $26,944,000 after purchasing an additional 13,835 shares during the last quarter. Raymond James Financial Inc. purchased a new stake in shares of Perrigo during the fourth quarter worth approximately $3,177,000. Finally, Norges Bank acquired a new position in Perrigo during the fourth quarter worth $36,614,000. Hedge funds and other institutional investors own 95.91% of the company's stock.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.